AGAR Group

Menu

2022 Meetings

November 2022 Meeting:

AGAR EXECUTIVE MEETING AGENDA NOVEMBER 2022 (PDF)
2. AGAR Executive Meeting Minutes 24th June 2022 (PDF)
4.1 NAPS Program - Kaz Thursky (PDF)
4.2. NAPS Program Embargo - Kaz Thursky Embargo (PDF)
5.AGAR 2022 Operating Procedures (PDF)
6. AGAR 2022 Data Governance and Managment Plan (PDF)
7.1. AGAR June 2022 Financial Report (PDF)
7.2. AGAR 2021-2022 Financial Report (PDF)
7.3. AGAR September 2022 Financial Report (PDF)
8.1. 2021 Program Budget (PDF)
8.2. ASSOP 2021 FINAL REPORT (PDF)
8.3. AESOP 2021 FINAL REPORT (PDF)
8.4. GNSOP 2021 FINAL REPORT (PDF)
8.9. ASA BREAKPOINT (PDF)
9. 2022 Program Budget 26102022 (PDF)
10.1. AGAR Paeditric Committee Meeting Minutes 10 May 2022 (PDF)
10.2. Draft AGAR Paediatric Data Analysis Plan 20221024 (PDF)
13.1. AGAR 2021 data for GLASS 2022 submission (PDF)
13.2. GLASS 2021 AGAR Data (xlsx)
13.3. GLASS MEETING NOTES (PDF)
15.1. AGAR Deliverable Letter 29072022 (PDF)
15.2. AGAR Progress Report 29072022 (PDF)
15.3. AGAR 2022 Project Plan (PDF)
16. AGAR Website Quote (PDF)
17.1. AGAR Web Portal Access (PDF)
19.1. CSIRO AMR Report (PDF)
19.2. Molecular epidemiology of penillin susceptible SAB (PDF)

June 2022 Meeting:

AGAR EXECUTIVE MEETING AGENDA JUNE 2022 (PDF)
AGAR EXECUTIVE MEETING MINUTES AUGUST 19TH (PDF)
3.1 RENAMING AGAR SEPSIS PROGRAM (PDF)
4.1. AON INSURANCE EMAIL (PDF)
4.2. AON POLICY SCHEDULE (PDF)
4.3. QLD CHILDREN’S HOSPITAL PARTICIPATION (PDF)
4.4. ETHICS HREC QPATH ANNUAL PROGRESS REPORT (PDF)
5.AGAR 2022 OPERATING PROCEDURES (PDF)
6. AGAR 2022 DATA GOVERNANCE AND MANAGEMENT PLAN (PDF)
7.1. AGAR MARCH 2022 FINANCIAL REPORT (PDF)
8.1. CDI ASSOP 2020 (PDF)
8.2. CDI AESOP 2020 (PDF)
8.3. CDI GNSOP 2020 (PDF)
9.1. 2021 PROGRAM BUDGET (PDF)
9.2. DOH 2021 ASSOP DRAFT REPORT (PDF)
9.3. DOH 2021 AESOP DRAFT REPORT (PDF)
9.4. DOH 2021 GNSOP DRAFT REPORT(PDF)
10.1. 2022 AGAR PROGRAM BUDGET (PDF)
11.1. AGAR PAEDIATRICS PROGRAM MEETING 10 MAY 2022 AGENDA (PDF)
11.2. AGAR PAEDIATRICS PROGRAM MEETING 10 MAY 2022 MINUTES (PDF)
11.3. CAMPBELL ET AL CID 2022 (PDF)
11.4. CAMPBELL ET AL JAC 2020 (PDF)
12.1. GNSOP 2020 CHROMOSOMAL AMR (PDF)
12.2. GNSOP 2020 PLASMID AMR (PDF)
13.1. ASSOP 2020 PENICILLIN SUSCEPTIBLE S AUREUS REPORT (PDF)
13.2. VVE AND DAP R SA PROGRESS REPORT (PDF)
16.1. 2022 AGAR ADDITIONAL PROJECTS (PDF)
16.2. AMR POLICY SECTION LEADER (PDF)
16.3. PROGRESS REPORT E21-52135 SUBMITTED (PDF)
19.1. GENEVIEVE MCKEW 1 – PSSA (PDF)
19.2. GENEVIEVE MCKEW 2 – PROTOCOL PSSA (PDF)
19.3. RAVIN HETTIARACHCHI – PSSA (PDF)
19.4. NAOMI RUNNEGARAGAR UTI-BSI DATA UPDATE (PDF)
20.1 CONSULTATION COVER LETTER (PDF)
20.2 DRAFT BEST PRACTICE MODEL FOR AMR PHL SURVEILLANCE_DUE 10 JUNE 2022 (PDF)
20.3 AGAR NNN RESPONSE SUBMITTED (PDF)

March 2022 Meeting:

AGAR Executive Meeting Agenda March 2022 (PDF)
AGAR Executive Meeting Minutes August 19th  (PDF)
4.1. 2020 Australian Data Submission GLASS (PDF)
4.2. Australian GLASS Data Submission 2020 (PDF)
4.3. AURA 2021 Website (PDF)
4.4. Thank you for Participating in AURA 2021 Launch (PDF)
4.5. AGAR ASTAG (PDF)
4.6. RPAH AGAR 2021 (PDF)
4.7. Sepsis Terminology (PDF)
5. AGAR 2022 Operating Procedures (PDF)
6. Revised AGAR 2022 Data Governance and Management Plan (PDF)
7.1. AGAR June 2021 Financial Report (PDF)
7.2. AGAR 2020-2021 Financial Report (PDF)
7.3. AGAR September 2021 Financial Report (PDF)
7.4. AGAR December 2021 Financial Report
8.1. 2020 AGAR Program Budget
8.2. DoH Acceptance of AGAR 2020 Deliverables
8.3. AGAR 2020 Amalgam Report
8.4. ASSOP 2020 CDI Manuscript
8.5. AESOP 2020 CDI Manuscript
8.6. GnSOP 2020 CDI Manuscript
9.1. AURA 2021 Report
9.2. AURA 2021 Highlights
10.1.1. DoH Letter of Offer
10.1.2. Project Plan
10.1.3. 2021 to 2024 Contract
10.1.4. COI Declaration
10.2.1. ASSOP Daptomycin Resistant S aureus
10.2.2. AESOP VVRE
10.3. Jennie Hood Resignation Letter
10.4. AURA Program Partner Virtual Meeting 22 Dec 2021
10.5. Deliverable Templates
11.1. 2021 AGAR Surveillance Programs
11.2. 2021 AGAR Program Budget
11.3. 2021 AGAR Progress Report
12. 2022 AGAR Laboratories
15.1.1. SNAP Core Protocol
15.1.2.SNAP Summary
15.1.3. SNAP ASA Collaboration Agreement
16.1. WHOCC – Doherty
16.2. AGAR Kids Chris Blyth
16.3. AGAR Kids 2 Chris Blyth

Copyright © 2004-2022 Australian Group on Antimicrobial Resistance (AGAR). Last Updated December 2017.